Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Global Collagen And HA-Based Biomaterials Industry

Table 60: European Historic Review for Collagen and HA-basedBiomaterials by Product Group/ Segment - Collagen BasedBiomaterials (Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillersand WoundDressings); and Hyaluronic Acid Based Biomaterials(Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-40

Table 61: European 15-Year Perspective for Collagen andHA-based Biomaterials by Product Segment - PercentageBreakdown of Dollar Sales for Collagen Based Biomaterials(Urinary Incontinence Products, Corneal Shields, FacialAesthetic Dermal Fillersand Wound Dressings); and HyaluronicAcid Based Biomaterials (Viscosupplements, Viscoelastics andFacial Aesthetic Dermal Fillers) Markets for Years 2004,2012 & 2018 (includes corresponding Graph/Chart) III-41

4a. FRANCE III-42A.Market Analysis III-42Current and Future Analysis III-42Hyaluronic Acid Based Biomaterials III-42Collagen Based Biomaterials III-42Sanofi SA ( France) - A Key Player III-42B.Market Analytics III-43Table 62: French Recent Past, Current & Future Analysis forCollagen and HA-based Biomaterials by Product Group/Segment- Collagen Based Biomaterials (Urinary IncontinenceProducts, Corneal Shields, Facial Aesthetic DermalFillersand Wound Dressings); and Hyaluronic Acid BasedBiomaterials (Viscosupplements, Viscoelastics and FacialAesthetic Dermal Fillers) Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-43

Table 63: French Historic Review for Collagen and HA-basedBiomaterials by Product Group/Segment - Collagen BasedBiomaterials (Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillersand WoundDressings); and Hyaluronic Acid Based Biomaterials(Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-44

Table 64: French 15-Year Perspective for Collagen andHA-based Biomaterials by Product Segment - PercentageBreakdown of Dollar Sales for Collagen Based Biomaterials(Urinary Incontinence Products, Corneal Shields, FacialAesthetic Dermal Fillersand Wound Dressings); and HyaluronicAcid Based Biomaterials (Viscosupplements, Viscoelastics andFacial Aesthetic Dermal Fillers) Markets for Years 2004,2012 & 2018 (includes corresponding Graph/Chart) III-45

4b. GERMANY III-46A.Market Analysis III-46Current and Future Analysis III-46Hyaluronic Acid Based Biomaterials III-46Collagen Based Biomaterials III-46Strategic Corporate Developments III-46B.Market Analytics III-48Table 65: German Recent Past, Current & Future Analysis forCollagen and HA-based Biomaterials by Product Group/Segment- Collagen Based Biomaterials (Urinary IncontinenceProducts, Corneal Shields, Facial Aesthetic DermalFillersand Wound Dressings); and Hyaluronic Acid BasedBiomaterials (Viscosupplements, Viscoelastics and FacialAesthetic Dermal Fillers) Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-48

Table 66: German Historic Review for Collagen and HA-basedBiomaterials by Product Group/Segment - Collagen BasedBiomaterials (Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillersand WoundDressings); and Hyaluronic Acid Based Biomaterials(Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-49

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs